2026-2027 China Mother & Baby Industry: High-Quality Growth and Market Value Insights Report
Wu Can Business Insights
The maternal and infant industry has shifted from an era of rapid expansion to one focused on deep value extraction. Despite a birth rate dropping below 800 million (a year-over-year decline of 17%), the $2 trillion market remains resilient, with projections suggesting it could surpass 4.8 trillion by 2026. The industry's core logic has undergone a historic transformation: moving from growth driven by demographic dividends to a strategy centered on increasing per-customer value and deepening engagement within existing markets. Against an irreversible decline in birth rates, only those who can build a competitive advantage combining "scientific research barriers," "AI capabilities," and "relationship-driven thinking" will prevail in this elimination contest for the 4.8 trillion market. This is not merely a cyclical fluctuation; it represents a fundamental paradigm shift.
Report generated byWu Can Business InsightsWriteThink Tank OnlineProofread8.18 Baby & Mom OscarJointly released.
"2026-2027 China Maternal and Infant Industry: Insights on High-Quality Growth and Market Value"The core thesis is simple: the "demographic dividend" in the maternal and infant industry has ended, but the "single-customer value dividend" is just beginning. The industry isn't failing; rather, the logic of "making money from the number of children" no longer works. The golden window for "earning through deep single-customer value" opens fully between 2026 and 2027. Players who simultaneously master the three keys—"medical-grade expertise," "AI-driven digitalization," and "relationship-based channels"—will capture most of the consolidation benefits during this phase of structural maturity.
Report clearly indicates2026 is a turning point year for the maternal and infant industry.Two major policies have been implemented simultaneously:
Research: Distinguishing Truth from FalsehoodThe competitive focus has shifted from "formulation wars" to "raw materials, standards, and clinical evidence." Patent portfolios in areas such as HMOs, medical foods, and active nutrients have become key barriers.
AI moving from virtual to real:Full-chain penetration from R&D (AI-driven formula design), manufacturing (flexible production), products (AIoT smart hardware evolving from "feature phones" to "virtual nannies"), to services (AI-redefined service delivery). To address the critical issue of "trustworthiness" in AI parenting scenarios, brands must ensure a triple guarantee: human oversight, traceability, and verifiability.
Offline store shake-up:Shift from "selling products" to "selling scenarios + services," solidifying a dual structure led by national giants and dominated by regional leaders. Price wars remain the core constraint, while declining birth rates rank only fifth in impact.
Regional Segmentation:East China: "Premium categories + instant retail + professional services"; South China: one of the few regions still benefiting from demographic dividends, but must drive growth with "major brands + niche categories"; Northeast: abandon scale illusions and focus on high-margin depth; Southwest: "small-pack penetration + healthcare value-add + community operations".
Content from the "2026-2027 China Maternal and Infant Industry High-Quality Growth and Market Value Insight Report" published by Wucan Business Observation. Scan the QR code to add our staff member for a free full copy; please state your purpose when applying.
